Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 5
2004 7
2005 4
2006 6
2007 8
2008 5
2009 7
2010 11
2011 10
2012 8
2013 4
2014 12
2015 8
2016 16
2017 9
2018 13
2019 11
2020 13
2021 16
2022 20
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Inter-fractional error and intra-fractional motion of prostate and dosimetry comparisons of patient position registrations with versus without fiducial markers during treatment with carbon-ion radiotherapy.
Iwai Y, Mori S, Ishikawa H, Kanematsu N, Matsumoto S, Nakaji T, Okonogi N, Kobayashi K, Wakatsuki M, Uno T, Yamada S. Iwai Y, et al. Among authors: yamada s. Radiol Phys Technol. 2024 May 1. doi: 10.1007/s12194-024-00808-8. Online ahead of print. Radiol Phys Technol. 2024. PMID: 38691309
Dose-averaged LET optimized carbon-ion radiotherapy for head and neck cancers.
Koto M, Ikawa H, Inaniwa T, Imai R, Shinoto M, Takiyama H, Isozaki T, Mizuno H, Kohno R, Takahashi I, Yoshida N, Yamada S. Koto M, et al. Among authors: yamada s. Radiother Oncol. 2024 May;194:110180. doi: 10.1016/j.radonc.2024.110180. Epub 2024 Feb 24. Radiother Oncol. 2024. PMID: 38403023 Free article.
A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
Okonogi N, Murata K, Yamada S, Habu Y, Hori M, Kurokawa T, Inaba Y, Fujiwara T, Fujii Y, Hanawa M, Kawasaki Y, Hattori Y, Suzuki K, Tsuyuki K, Wakatsuki M, Koto M, Hasegawa S, Ishikawa H, Hanaoka H, Shozu M, Tsuji H, Usui H. Okonogi N, et al. Among authors: yamada s. Int J Mol Sci. 2023 Jun 23;24(13):10565. doi: 10.3390/ijms241310565. Int J Mol Sci. 2023. PMID: 37445743 Free PMC article. Clinical Trial.
192 results